TechTaffy

tech:

taffy

Atomwise enters into an evaluation agreement with Pfizer

By TechTaffy Desk

Atomwise has entered into an evaluation agreement with Pfizer, in which the drug giant will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer.

Atomwise will computationally analyze millions of diverse small molecules for each of Pfizer’s identified target proteins using its AI platform, to predict those that may bind with high affinity to the selected target proteins.

Pfizer will pay a technology access fee and additional success-based payments for each target protein of interest, the companies said in a statement.

[Image courtesy: Atomwise]

Just in

Around the web

Windows 11 Start menu ads are now rolling out to everyone — The Verge

Microsoft is starting to enable ads inside the Start menu on Windows 11 for all users, writes Tom Warren. 
Around the web

Biden signs TikTok ‘ban’ bill into law, starting the clock for ByteDance to divest it — The Verge

President Joe Biden signed a foreign aid package that includes a bill that would ban TikTok if China-based parent company ByteDance fails to divest the app within a year, writes Lauren Feiner.
IT

IBM to acquire HashiCorp for $6.4B

IBM and HashiCorp have entered into an agreement for IBM to acquire HashiCorp, a provider of infrastructure and security management products, for $6.4 billion.
AI

OpenAI introduces new enterprise features

OpenAI announced new features aimed at enterprise users on Tuesday, at the wake of Meta's recent LLama 3 announcement.
Around the web

Oracle is moving its world headquarters to Nashville to be closer to health-care industry — CNBC

Oracle Chairman Larry Ellison said Tuesday that the company is moving its world headquarters to Nashville, Tennessee, to be closer to a major health-care epicenter, writes Ashley Capoot.